FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

1514151000168100: Australian Black Triangle Scheme reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Dec 2020. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
4501271000168110 Australian Black Triangle Scheme reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4501281000168113 Australian Black Triangle Scheme reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501291000168111 Black Triangle Scheme reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501301000168112 BTS (Black Triangle Scheme) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
4501421000168113 <p>Supports the identification of AMT TPUU and CTPP concepts that are associated with medicines where reporting adverse events are encouraged under the Black Triangle Scheme. </p><p>This reference set can be used by prescribing and dispensing software vendors to identify medications where reporting of adverse events is encouraged under the Black Triangle Scheme.</p><p><span><b>Target client</b>: This reference set was developed by the National Clinical Terminology Service, based on information from the Therapeutic Goods Administration (TGA), to support the reporting of adverse events, and can be used by developers to assist with the identification of medicines associated with the Black Triangle Scheme.</span><br></p> en Definition Active Case sensitive Australian Medicines Terminology module


1411 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Black Triangle Scheme reference set Is a Reference sets for Medications true Inferred relationship Some
Black Triangle Scheme reference set Is a Simple type reference set true Inferred relationship Some
Black Triangle Scheme reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 494774926
Black Triangle Scheme reference set Developed by Australian Digital Health Agency true Inferred relationship Some 254185599

Members
Vyxeos powder for injection, vial
Welireg 40 mg tablet
Welireg 40 mg tablet, 90, bottle
Xadago 100 mg tablet
Xadago 100 mg tablet, 10, blister pack
Xadago 100 mg tablet, 30, blister pack
Xadago 50 mg tablet
Xadago 50 mg tablet, 10, blister pack
Xadago 50 mg tablet, 30, blister pack
Xarelto 1 mg/mL granules
Xarelto 1 mg/mL granules, 100 mL, bottle
Xarelto 1 mg/mL granules, 50 mL, bottle
Xeljanz 10 mg tablet
Xeljanz 10 mg tablet, 14, blister pack
Xeljanz 10 mg tablet, 56, blister pack
Xeljanz 5 mg tablet
Xeljanz 5 mg tablet, 14, blister pack
Xeljanz 5 mg tablet, 180, bottle
Xeljanz 5 mg tablet, 56, blister pack
Xeljanz 5 mg tablet, 60, bottle
Xeljanz XR 11 mg modified release tablet
Xeljanz XR 11 mg modified release tablet, 14, bottle
Xeljanz XR 11 mg modified release tablet, 28, blister pack
Xeljanz XR 11 mg modified release tablet, 30, bottle
Xeljanz XR 11 mg modified release tablet, 7, blister pack
Xembify 10 g/50 mL injection, 50 mL vial
Xembify 10 g/50 mL injection, 50 mL vial
Xembify 2 g/10 mL injection, 10 mL vial
Xembify 2 g/10 mL injection, 10 mL vial
Xermelo 250 mg tablet
Xermelo 250 mg tablet, 90, blister pack
Xevudy 500 mg/8 mL injection, 8 mL vial
Xevudy 500 mg/8 mL injection, 8 mL vial
Xiidra 5% eye drops, 0.2 mL unit dose
Xiidra 5% eye drops, 20 x 0.2 mL unit doses, ampoule
Xiidra 5% eye drops, 60 x 0.2 mL unit doses, ampoule
Xofluza 20 mg tablet
Xofluza 20 mg tablet, 2, blister pack
Xofluza 40 mg tablet
Xofluza 40 mg tablet, 2, blister pack
Xospata 40 mg tablet
Xospata 40 mg tablet, 84, blister pack
Xpovio 20 mg tablet
Xpovio 20 mg tablet, 16, blister pack
Xpovio 20 mg tablet, 20, blister pack
Xpovio 20 mg tablet, 24, blister pack
Xpovio 20 mg tablet, 32, blister pack
Xultophy injection, 3 mL pen device
Xultophy injection, 3 mL pen device
Xultophy injection, 3 x 3 mL pen devices
Xultophy injection, 5 x 3 mL pen devices
Yondelis 1 mg powder for injection, 1 mg vial
Yondelis 1 mg powder for injection, 1 vial
Yondelis 250 microgram powder for injection, 1 vial
Yondelis 250 microgram powder for injection, 250 microgram vial
Zavicefta 2000/500 powder for injection, 10 x 2.5 g vials
Zavicefta 2000/500 powder for injection, 2.5 g vial
Zebinix 200 mg tablet
Zebinix 200 mg tablet, 20, blister pack
Zebinix 200 mg tablet, 60, blister pack
Zebinix 800 mg tablet
Zebinix 800 mg tablet, 180, blister pack
Zebinix 800 mg tablet, 20, blister pack
Zebinix 800 mg tablet, 30, blister pack
Zebinix 800 mg tablet, 60, blister pack
Zebinix 800 mg tablet, 90, blister pack
Zejula 100 mg capsule
Zejula 100 mg capsule, 28, blister pack
Zejula 100 mg capsule, 56, blister pack
Zejula 100 mg capsule, 84, blister pack
Zejula 100 mg capsule, 90, bottle
Zeposia 230 microgram capsule
Zeposia 460 microgram capsule
Zeposia 920 microgram capsule
Zeposia 920 microgram capsule, 28, blister pack
Zeposia Initiation Pack (4 x 230 microgram capsules, 3 x 460 microgram capsules), 7, blister pack
Zolgensma 20 trillion vector genomes/mL injection, 5.5 mL vial
Zolgensma 20 trillion vector genomes/mL injection, 8.3 mL vial
Zolgensma 20 trillion vector genomes/mL injection, 2 x 5.5 mL vials
Zolgensma 20 trillion vector genomes/mL injection, 2 x 8.3 mL vials
Zolgensma 20 trillion vector genomes/mL injection, 3 x 8.3 mL vials
Zolgensma 20 trillion vector genomes/mL injection, 4 x 8.3 mL vials
Zolgensma 20 trillion vector genomes/mL injection, 5 x 8.3 mL vials
Zolgensma 20 trillion vector genomes/mL injection, 5.5 mL vial
Zolgensma 20 trillion vector genomes/mL injection, 6 x 8.3 mL vials
Zolgensma 20 trillion vector genomes/mL injection, 7 x 8.3 mL vials
Zolgensma 20 trillion vector genomes/mL injection, 8 x 8.3 mL vials
Zolgensma 20 trillion vector genomes/mL injection, 8.3 mL vial
Zolgensma 20 trillion vector genomes/mL injection, 9 x 8.3 mL vials
Zolgensma Combination Pack (1 x 5.5 mL vial, 2 x 8.3 mL vials), 1 pack
Zolgensma Combination Pack (1 x 5.5 mL vial, 3 x 8.3 mL vials), 1 pack
Zolgensma Combination Pack (1 x 5.5 mL vial, 4 x 8.3 mL vials), 1 pack
Zolgensma Combination Pack (1 x 5.5 mL vial, 5 x 8.3 mL vials), 1 pack
Zolgensma Combination Pack (1 x 5.5 mL vial, 6 x 8.3 mL vials), 1 pack
Zolgensma Combination Pack (1 x 5.5 mL vial, 7 x 8.3 mL vials), 1 pack
Zolgensma Combination Pack (1 x 5.5 mL vial, 8 x 8.3 mL vials), 1 pack
Zolgensma Combination Pack (2 x 5.5 mL vials, 1 x 8.3 mL vial), 1 pack
Zolgensma Combination Pack (2 x 5.5 mL vials, 2 x 8.3 mL vials), 1 pack
Zolgensma Combination Pack (2 x 5.5 mL vials, 3 x 8.3 mL vials), 1 pack
Zolgensma Combination Pack (2 x 5.5 mL vials, 4 x 8.3 mL vials), 1 pack
Zolgensma Combination Pack (2 x 5.5 mL vials, 5 x 8.3 mL vials), 1 pack

Start Previous Page 14 of 15 End


Reference Sets

Reference set descriptor

Back to Start